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1. Introduction  
CRC is one of the most frequently diagnosed neoplastic disorders in humans worldwide. 
According to the National Centre for Health Information of Bulgaria the prevalence of CRC 
for 2005 is 304.6/100 000 cases, and the incidence - 49.2/100 000 cases (Bulletin of the 
National Centre for Health Information, 2005). Colorectal polyps (CRP) are established 
precursors of CRC. Hence, elimination of precursors is a well-known strategy for reduction 
of risk. In the last decade the most extensively studied etiologic factors are the risk factors 
for colorectal cancer development, because of its growing incidence and the possibility for 
its prevention. Prophylaxis of CRC we can divide in primary, secondary and tertiary. The 
most widely used chemopreventive drugs are: acetylsalicylic acid, polyvitamins, calcium, 
folic acid, selenium and NSAID. 
2. Risk and protective factors for colorectal polyps and cancer  
Today it is widely accepted that colorectal polyps (CRP) are preneoplastic lesions of 
colorectal cancer (CRC). From the 3 major groups of polyps: adenomas, hyperplastic, and 
serrated polyps, with the first group having the highest malignant potential. Hyperplastic 
polyps are the most common benign lesions, possessing very low malignant potential, and 
therefore do not require colonoscopic surveillance. However, recent studies prove their role 
in the classical model of adenoma-carcinoma sequence, and reveal common molecular 
features between normal mucosa, colorectal polyps, and cancer: proliferation activity, p53 
overexpression, hypomethylation of c-myc, and mutations in k-ras oncogene (Hamilton, 
2001). Progression of adenomas to CRC has been proven by the 'multistep model' of 
carcinogenesis, proposed by Fearon and Vogelstein. According to this model the stepwise 
progression of aberrant crypt foci, small, middle and large adenoma to carcinoma is 
accompanied by accumulation of mutations in the genes APC, k-ras, DCC, and p53 (Fearon,  
Fogelstein, 1990). Serrated polyps are histologicaly characterized by 'saw-tooth' infolding of 
the crypt epithelium, and are seen in 1% of the cases (Longacre & Fenoglio-Preiser, 1990). 
Every adenoma of the colorectum has a 5% probability for malignant transformation 
(Winawer et al., 1997). The growth of small adenomas is slow, requiring 10 years on average 
for doubling of their size (Hoff, 1987). The percentage of transformation of small adenomas 
into carcinomas is 0.25% (Eide, 1986). CRC is caused by complex interactions between host 
genetic susceptibility and certain exogenous risk factors. Geographic variation underscores 
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the importance of environmental factors in CRC pathogenesis, since a 30-40 fold difference 
between regions with high and low incidence has been found (Parkin et al., 1999). It is 
famous that the main risk factors for CRC and CRP are obesity, high calories intake, high 
body mass index (BMI), and low physical activity, consumption of red meat and animal fats, 
and alcohol. Other risk factors include male gender, advancing age, use of laxatives, 
constipation, pathological gut flora, some occupations, and intake of Fe-containing 
supplements. There is association also between the risk of developing CRC or CRP and 
presence of some diseases like inflammatory bowel disease (IBD), acromegaly, diabetes 
mellitus, cholecystectomy, ovarian and breast cancer, history of survived cancer or 
availability of adenomatous polyps in the past. Many conditions increase the risk of 





Risk factor Minimal Moderate Major 
Dominant  inheritance  (FAP, HNPCC, Juvenile 
polyposis) 
  + 
Diet   + 
Recessive inheritance or low penetration  (MAP)  +  
CRC in the past  +  
Colorectal villous adenoma in the past  +  
Low physical activity  +  
Age > 50 y.  +  
Male gender +   
Obesity +   
Tobacco smoking +   
Chronic alcohol abuse +   
Extensive IBD +   
Acromegaly +   
Diabetes mellitus +   
Cholecystectomy +   
Breast cancer, ovarian cancer, radiotherapy +   
 
Тable 1. Assessment of risk factors for CRC and CRP. FAP, Familial adenomatous polyposis; 
NHPCC, Hereditary non-polyposis colorectal cancer; MAP, MYH-associated adenomatous 
polyposis; IBD, inflammatory bowel disease. 
3. Patients and methods (our study) 
3.1 Characteristics of patients with colorectal polyps and cancer  
One-hundred and sixty six patients diagnosed for large bowel polyps were included in 
the present study. Of the patients, 76 were female and 90 male, aged 60±13 years (range 
19-86 years). Also, 107 patients with CRC (48 female and 59 male) aged 64±11 years (range 
32-94 years), 3 patients with familial adenomatous polyposis (FAP), and 2 patients with 
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Peutz-Jeghers syndrome, aged 31±12 years were included in the study. As a control we 
used a group of 42 healthy individuals (18 female and 24 male), aged 55±12 years, to 
whom upper and lower endoscopy was performed at their will or as a screening 
procedure, but showed no changes. Careful personal history, including dietary habits, 
physical examination, and anthropometric data were taken from all patients. We studied 
some factors from the lifestyle and diet in our patients with CRC and CRP, and looked for 
any connection between these factors and the beginning of CRC and CRP. For the aim of 
our study, we divided food consumed from the patients into 13 groups as follows: I. Milk 
and dairy products; II. Eggs; III. Meat and meat products; IV. Fish and sea animals; V. 
Cereals and pasta; VI. Sugar and sweets; VII. Legumes; VIII. Nuts; IX. Fats; X. Vegetables; 
XI. Fruits; XII. Spices; XIII. Beverages. We tried to establish the preferred way of cooking 
and favorite drinks in the studied patients. We registered their dietary habits in 
qualitative and quantitative manner, until the moment of CRC or CRP occurrence. We 
analyzed family predisposition of the included patients and their exposition to deleterious 
exogenous factors. All information, including clinical data, endoscopic and histological 
results, surveillance, and treatment, was entered on personal cards and in a 
gastrointestinal register for polyps and cancer.  
3.2 Statistical analysis 
Logit-models were used for determining the possible risk or preventive factors, which 
combine regression and correlation analysis. We investigated the influence of these factors 
upon included patients with linear regression analysis to be able to associate the lifestyle 
and diet habits of population in our region. Depending on the value of the Exponent Ехp(B), 
factors are classified in three groups: risk factors – Exp(B)>1, protective factors – Exp(B) <1 
and indifferent factors – Exp(B)=1. Statistical analysis was performed using Microsoft Excel, 
Statistics 5. 13./W and SPSS 13.0 for Windows software programs. Values of p<0.05 were 
considered as statistically significant.  
4. Risk factors for colorectal polyps according to our data 
Our data find the following risk factors for colorectal polyps: consumption of red meat, 
meat products, sausages, fat food, high BMI, frequent use of laxatives, beer and alcohol 
intake, preserved foods, salty foods, grilled or barbecued meat, low physical activity, 
allergy, bacon, ham, margarine, fried food, preserved meat, sugar, marinated food, tobacco 
smoking, egg-fried food, working in heavy or petrol industry, presence of autoimmune 
disease, use of microwave oven, professional exposure to extremely low temperatures, 
passive smoking and elevated serum glucose level.  
We concluded that the most important risk factors for the development of colorectal polyps 
are diet factors - consumption of sugar products, fried, grilled and preserved food, animal 
fats and margarine, egg-fried food and obesity. The most important life style and 
occupational risk factors for the development of colorectal polyps are: chronic alcohol 
intake, long lasting tobacco smoking, minimal physical activity, occupational exposure to 
petrol and metals. The chronic alcohol intake includes usage of beer, wine and strong drink. 
Substantial factors are and presence of autoimmune disease or allergy, frequent use of 
laxatives and elevated serum glucose level. 
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Factor Intensity Exp. (B) 
Chronic alcohol abuse + + + 9,256 
Sugar and sweets  + + + 8,917 
Fried food  + + + 7,258 
Preserved food + + + 5,363 
Heavy industry workers + + + 5,259 
Beer + + + 5,025 
Meat delicacy  + + + 4,759 
Bacon  + + + 4,582 
Long lasting sausages + + + 4,265 
Fat food + + + 4,023 
Margarine +  + 3,707 
Exposure to petrol +  + 3,616 
Weekly consumption of grilled meal +  + 3,093 
Presence of autoimmune disease +  + 2,958 
Strong drink +  + 2,919 
Low physical activity +  + 2,843 
Wine +  + 2,827 
Salty food +  + 2,575 
Allergy +  + 2,566 
Grilled meat +  + 2,439 
Preserved meat +  + 2,345 
Ham +  + 2,241 
Smoked food  +  + 2,144 
Frequent use of laxatives + 1,796 
Marinated food + 1,658 
Preserved food + 1,511 
Egg-fried food + 1,448 
Tobacco smoking + 1,444 
Frequent meat consumption + 1,349 
Elevated serum glucose level + 1,115 
Years of alcohol consumption) + 1,074 
High body mass index (BMI)        + 1,047 
Years of smoking + 1,030 
Table 2. Risk factors for colorectal polyps (4,01 – 10,00  + + +), (2,01 – 4,00  +  +),  
(1,00 – 2,00 +).  
5. Protective factors for colorectal polyps according to our data 
According to our results fruits (apples, plumbs, raspberries, and pears), vegetables, rye- and 
whole-grain bread, green tea, vegetable food consumption, yoghurt, fasting, fish, lamb, 
hare, garlic, legumes and mineral water have a strong protective effect against large bowel 
polyps. 
The most significant protective factors against colorectal polyps are again diet factors - 
consumption of fruit, vegetables, rye- and whole-grain bread, vegetable food, green tea, 
yoghurt and fasting. Protective role plays and frequent consumption of fish, lamb and hare. 
Probably, conditions of rural life are connected with reduction of the risk factors for 
development of colorectal polyps. 
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Factor Intensity Exp. (B) 
Fruit + + + 0,033 
Rare consumption of 
grilled food 
+ + + 0,094 
Apples + + + 0,122 
Vegetables + + + 0,126 
Rye bread + + + 0,199 
Plumbs + + + 0,244 
Raspberries + + + 0,258 
Pears + + + 0,268 
Rural life + + 0,318 
Green tea + + 0,325 
Vegetable food + + 0,345 
Whole-grain bread + + 0,352 
Yoghourt + + 0,367 
Green vegetables + + 0,382 
Fasting + + 0,385 
Fish + + 0,428 
Lamb + 0,559 
Hares + 0,588 
Legumes + 0,595 
Garlic + 0,616 
Low salt diet  + 0,668 
Mineral water + 0,895 
Table 3. Protective factors for colorectal polyps (0,01 – 0,3  + + +), (0,31 – 0,50  + +),  
(0,51 – 1,00  +). 
6. Risk factors for colorectal cancer according to our data 
One of the most important aims of our study was to establish the risk factors for the CRC 
epidemic, which is observed now and in Bulgaria. We accomplished this study considering 
the specific conditions in our country and made comprehensive investigation of the diet 
habits of all included patients with colorectal polyps and cancer. We estimated and all other 
possible risk factors. Detailed list of risk factors for development of colorectal cancer is 
presented in Table 4.  
The major risk factors for CRC are dietary as well: consumption of fat food, red meat and 
meat diet as a whole, smoked and egg-fried food, sugar and sweets, white bread, obesity. 
The lifestyle has also a significant effect: long lasting alcohol intake (beer, wine, and spirits), 
tobacco smoking, minimal physical activity, urban life. We noticed and other risk factors for 
CRC development: H. pylori infection, presence of adenomas, diabetes mellitus, and 
frequent use of laxatives. Probably, urban life increases the exposition to many of the 
presented risk factors and therefore it is a specific risk factor for development of CRC. 
7. Protective factors for colorectal cancer according to our data  
According to our results consumption of dairy products, fruit, garlic, onions, fish, plant oil, 
boiled food, vegetables, fowls, legumes and white meat has a strong protective effect for 
CRC. Low salt diet, fasting, usage of acetylsalicylic acid and rural life also possess protective 
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Factor Intensity Exp. (B) 
Fat food + + + 11,034 
Adenomas with severe dysplasia + + + 10,784 
Smoked meat + + + 7,282 
Egg-fried food + + + 6,334 
Long lasting alcohol intake>10y + + + 5,939 
Sub-products + + + 5,625 
Fried food + + + 5,244 
Short lasting sausages + + + 4,646 
Pork + + + 4,368 
Sausages + + + 4,255 
Margarine + + + 4,214 
Beer + + + 4,095 
Bacon + + 3,366 
Tobacco smoking + + 3,622 
Meat delicacy + + 3,546 
Low gr. dysplastic adenomas + + 3,541 
Minimal physical activity + + 3,446 
Sugar and sweets + + 3,281 
Urban life + + 3,054 
Exposure to petrol + + 2.898 
Frequent use of laxatives + + 2,895 
Preserved food + + 2,339 
White bread + + 2,248 
Helicobacter pylori + + 2,204 
Red meat + 1,805 
Meat products + 1,508 
Wine + 1,414 
Tobacco smoking >10y  + 1,058 
Strong drink + 1,054 
Villous component in adenoma + 1,052 
Overweight and obesity + 1,045 
Diabetes mellitus + 1,040 
Age + 1,036 
Table 4. Risk factors for CRC (4,01 – 12,00  + + +), ( 2,01 – 4,00  +  +), (1,00 – 2,00  +).  
effect against development of CRC. Our data is similar to the findings of other authors 
(Zaridze, 1983). Detailed list of protective factors against development of CRC is presented 
in Table 5. 
The most important protective factors for CRC development are: consumption of fruit, 
vegetables, fasting, vegetable oil, fish, poultry, white meat, legumes, boiled food, and rare 
consumption of grilled meat. Regular use of acetylsalicylic acid and rural life are prominent 
protective factors for development of CRC. Obviously, diet regime in conditions of 
Bulgarian rural area is much closer to the healthy Balkan diet from the first half of the 20-th 
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Factor Intensity Exp. (B) 
Low salt diet + + + 0,001 
Melons + + + 0,051 
Dairy products + + + 0,071 
Pears + + + 0,114 
Acetylsalicylic acid + + + 0,119 
Garlic + + + 0,128 
Fasting + + + 0,133 
Fish + + + 0,137 
Poultry + + + 0,165 
Rural life + + + 0,197 
Water melons + + + 0,200 
Hares + + 0,202 
Onions + + 0,228 
Plant oil + + 0,231 
Grapes + + 0,235 
Peppers + + 0,264 
Fruit + + 0,294 
Vegetables + + 0,300 
Green vegetables + + 0,318 
Boiled food + + 0,343 
Fowls + + 0,367 
Legumes + 0,418 
Rare use of grilled meat + 0,430 
Fasting + 0,457 
White meat + 0,665 
Peaches + 0,668 
Table 5. Protective factors for CRC (0,01 – 0,2   + + +), ( 0,201 – 0,40   + +), ( 0,41 – 1,00 +). 
8. Risk and protective factors for colorectal polyps and colorectal cancer - 
summary  
Our data show that colorectal polyps and cancer share common risk and protective factors 
(Kotzev et al., 2008). This finding, paired with the high frequency of existence of colorectal 
polyps and CRC, could serve as an evidence of the role of the colorectal polyps as CRC 
precursors. Common risk and protective factors for colorectal polyps and colorectal cancer 
are summarized in Table. 6, where factors are divided into alimentary risk factors, 
nonalimentary risk factors and protective factors.  
9. The mode of action of risk and protective factors for colorectal polyps and 
cancer 
The mode of action of different risk and protective factors for CRC and CRP is associated 
with distinct pathogenetic mechanisms, which sometimes share similar pathways. 
9.1 Alimentary risk factors for colorectal polyps and cancer  
9.1.1 Obesity, high BMI and high caloric intake 
Obesity, high BMI and high caloric intake are associated with increased risk for cancer 
formation, including CRC (Giovannucci et al., 1995). These risk factors are connected with  
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Risk dietary factors Risk non-dietary factors Protective factors 
Overweight Low physical activity Carbohydrates (long chained) 






Contaminated water Gender Probiotics 
Fats Age Fibers 
Red meat Laxatives Flavonoids 
Sugar Helicobacter pylori Dairy products 
Alcohol Occupational risks Calcium 
Eggs Colorectal polyps Fluids 
Way of cooking - grilled meat IBD, diabetes. mellitus, 
ovarian  Ca, mammary Ca 
Vitt. A, B, C, D, folic acid, 
Selenium,  Calcium 
Way of cooking — fried meat Cholecystectomy Fruit and vegetables 
Way of cooking - high t° Radiotherapy Cereals 
Polyamines Colorectal cancer Bioactive components 
Table 6. Summary of  all protective and risk factors tor CRC and CRP. 
large bowel polyp formation as well. High caloric intake in combination with low physical 
activity leads to hyperinsulinemia and peripheral insulin resistance, which could result in 
high mucosal proliferative activity, reduced apoptosis, accumulation of free radicals, and 
mutagenesis. Being overweight could have an inappropriate influence on the immune 
system, could elevate the serum level of prolactine, and raise the sensitivity of the 
hypothalamo-hypophyseal axis. High BMI and high caloric intake are connected with 
elevated risk for development of CRC and colorectal adenomas according to different 
experimental animal studies and epidemiological studies (Ford, S. 1999). 
9.1.2 Food additives and contaminants 
Food contains various food additives, contaminants, fertilizers, herbicides, food dying 
agents, antibiotics and antimycotics. Increased mutageneity has been observed in faeces of 
patients with elevated risk for CRC formation (Villa et al., 1996). Food contains a lots of car-
cinogens and co-carcinogens such as free radicals, N-nitrous compounds, secondary bile 
acids, polyamines, and heterocyclic amines (used in food processing) (Parkin et al., 1999). 
Co-carcinogens usually need activation in the gut. Their activation and inactivation is 
maintained by the gut flora, some phytochemicals and metabolites. Meat processing leads to 
elevated carcinogen production. Meat and fish cooking leads to formation of heterocyclic 
amines, especially at high temperatures or when exposed to direct fire. Our study shows 
that grilled, fried and egg-fried foods are associated with high CRP formation, and fried and 
egg-fried foods are risk factors for CRC as well. We consider preserved food as a risk factor 
for CRP and CRC, while marinated food is associated with CRP. Some observations propose 
that gut bacteria could transform bile acids into secondary bile acids (deoxycholic and 
litocholic) which possess high toxicity and stimulate large bowel mucosal proliferation 
(Burnstein, 1993). Food fatty acids also alter the composition and the quantity of bile acids. 
Accelerated bowel transit time could diminish exposition time of mucosa to food 
carcinogens, and enlarged volume could dilute them. Thus food fibers bind, inactivate and 
carry out the luminal carcinogens.  
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9.1.3 Fats  
The first announcement of the relationship between high intake of fats and CRC dates from 
1969 (Wynder et al., 1969). The relationship between saturated/animal fatty acids and CRC 
risk is tight. Saturated fats play a crucial role in the initiation, promotion and progression of 
CRC. Saturated fats increase the bile excretion, which is followed by toxic impact upon 
colon epithelium and hyperproliferation (Burnstein, 1993). The current study proved that 
consumption of fatty foods, bacon, and margarine is strongly associated with CRP and CRC 
development. The results of animal studies report that in the animals, which are on high fat 
diet, elevated cell proliferation and free radicals are observed. Inflammation and oxidative 
stress play a significant role in human carcinogenesis, besuse DNA lesions and 
chromosomal instability could occur (Evans et al., 2004; Kryston et al., 2011; Sedelnikova et 
al., 2010). On the other hand omega-3 polyunsaturated fatty acids decrease inflammation, 
inhibit formation and progression of preneoplastic colorectal lesions (Anti et al., 1994). The 
so-called "Mediterranean" diet, which is rich in fish and sea products, reduces the risk for 
colorectal cancer. Our study proves that regular consumption of fish and sea products (more 
than twice a week) strongly prevents CRP and CRC. Probably, the protective effect of 
omega-3 polyunsaturated fatty acids is due to stimulation of apoptotic program, decrease of 
inflammation, mucous prostaglandins and decrease of the secondary bile salts 
concentration, which are promoters for CRC. There are data that omega-3 polyunsaturated 
fatty acids modulate the action of COX-2 and induce the expression of 15-
hydroxyprostaglandin dehydrogenase, a physiologic COX-2 antagonist (Lim et al., 2008).  
9.1.4 Carbohydrates 
It is believed that decreased intake of carbohydrates reduces the risk for polyp formation 
(Lubin et al., 1997). Complex long-chained carbohydrates are considered highly protective 
in contrast to saccharose (World Cancer Research Fund and American Institute for Cancer 
Research, Food, Nutrition and the Prevention of Cancer: A Global Perspective., 1997). Some 
studies confirm that persistent hyperglicaemia and the subsequent insulin release are 
stimuli for hyperproliferation of colon epithelium and risk factors for the development of 
CRC (Calle & Thun, 2004). In contrast, other studies did not observe such an association 
(Weijenberg et al., 2008). Complex long-chained carbohydrates must supply 46-60% of all 
energy intake, while refined saccharose must supply <10% according to some 
recommendations (World Cancer Research Fund and American Institute for Cancer 
Research, Food, Nutrition and the Prevention of Cancer: A Global Perspective., 1997). The 
results of this study support the notion that saccharose and sweets are risk factors for CRP 
and CRC, while complex long-chained carbohydrates have protective effect. 
9.1.5 Red meat  
Consumption of red meat is connected with development of CRC (Ferrucci et al., 2009). Our 
study also confirmed the fact that regular consumption of red meat, large amounts of meat 
and meat products, preserved meat, ham, long- and short lasting sausages, pork, sub-
products, and meat delicacy, is strongly associated with CRP, and CRC initiation and 
progression. On the other hand intake of fish, hare, lamb, white meat and poultry are highly 
protective. The possible pro-carcinogenic effect of red meat could be explained by the 
elevated heme iron content which could serve as a source for production of free radicals and 
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mucosal hyperproliferation (Nelson, 2001). The results obtained by other studies deny the 
role of dietary Fe and iron status for CRC development (Tseng et al., 1997). N-nitrous 
compounds in the red meat and produced during the food processing with high 
temperature polycyclic carbohydrates and heterocyclic amines are also possible reasons for 
the harmful effect of red meat (De Meester & Gerber, 1995) Red meat consumption in 
elderly individuals should be limited to 70-80g/day. 
9.1.6 Alcohol  
We believe that chronic alcohol abuse is a major risk factor for gastrointestinal polyps and 
cancer formation in esophagus, stomach, colon and rectum. High alcohol intake (>21 
units/week) of beer, wine and spirits significantly increases the risk for CRP and CRC. 
These findings are probably due to the effect of acetaldehyde, which damages colorectal 
mucosa and elevates cell regeneration. Folic acid and methionine deficiency in persons who 
chronically abuse with alcohol are also risk factors for development of CRC (Giovannucci  et 
al., 1995). Alcohol is an inducer of cytochrome P-405 2E1, which contributes to increased 
production of free radicals (Seitz & Osswald, 1992). Alcohol diminishes the transformation 
of retinol into retinoic acid and as result cell proliferation is upregulated (Seitz et al., 1998). 
9.1.7 Food processing 
We found that fried and grilled food is a risk factor for CRC and CRP. Cooking of the food 
at high temperatures and usage of grill induces formation of heterocyclic amines in the 
meat, which own mutagenic and pro-carcinogenic activity (Sigimura et al., 2004; De Meester 
& Gerber, 1995). Biochemical interactions between proteins, carbohydrates and fats during 
food processing are also of great importance for the formation of carcinogenic compounds.  
9.2 Nonalimentary risk factors for colorectal polyps and cancer 
9.2.1 Physical activity  
Five percent of cardiovascular mortality rate is caused by low physical activity. 13% is the 
estimated value for CRC (Slattery & Potter, 2002). This is probably due to the combination of 
low physical activity, nutrition, lifestyle, and their cross-interactions. The mode of action of 
physical activity upon CRC is not clear, but decrease in inflammation and insulin levels is 
supposed. A middle intensive physical activity 3-4 times per week with 1.5 h duration is 
advisable. Increased physical activities, especially in men, reduce the risk for CRC with 40-
50% (Scottish Intercollegiate Guidelines Network. Management of Colorectal cancer. A 
national clinical guideline., 2003). 
9.2.2 Tobacco smoking 
Many authors consider CRC as tobacco-related, taking into account the duration of 
smoking. It is estimated that 12% of the cases of CRC are related to smoking (Courtney et al., 
2004). The present study confirmed the role of tobacco smoking as a risk factor for CRP and 
CRC. The risk is elevated proportionally to the years of smoking. Tobacco smoking disrupts 
conjugation of glutathione, cytochromes and damages DNA (Pfohl-Leskowitcz et al, 1999). 
Inhalation of carcinogens from tobacco smoke could trigger microsatellite instability (Yang 
et al., 2000). 
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The incidence of CRC is almost always higher in men (Parkin et al., 1999). Our data support 
these findings, as the men/women ratio was 1.2/1 in patients with CRP and 1.23/1 in 
patients with CRC. These differences could be explained with different life style, diet habits, 
physical activity, tobacco smoking, and consumption of alcohol, usage of NSAID and iron 
stores. There are and speculations about the protective role of female sex hormones 
(Crandall, 1999). Hormone replacement therapy in women is not recommended, because of 
the risk of vascular damages, thromboembolism and breast cancer (Scottish Intercollegiate 
Guidelines Network. Management of Colorectal cancer. A national clinical guideline, 2003).  
9.2.4 Age 
The interacting reasons for neoplastic changes in the colon are clinically manifested as a 
CRC during the second half of life. The mean age of our patients with CRP is 60 years and 
the mean age of our patients with CRC is 64 year. The mortality rate is increasing in parallel 
with advancing age according to reported data (Crandall, 1999). 
9.2.5 Laxatives use 
Frequent use of laxatives is among risk factors according to our data. This result is 
supported by some other studies (Van Gorkom et al., 1999). Probably, laxatives exert direct 
toxic effect upon colon mucosa.  
9.2.6 Iron and haemochromatosis 
The presumable mechanism of iron influence as a risk factor for CRC is connected with the 
formation of the free radicals from the unabsorbed iron, which damage colon epithelium. 
Heterozygotic patients who have not developed haemochromatosis are at elevated risk of 
developing CRC (Altes et al., 1999). The high risk of developing CRP and CRC in our 
patients who have regularly consumed red meat could be partially explained with the high 
amount of organic iron, which is available in the heme molecule. 
9.2.7 Occupation 
Our data show that exposure to petrol and metal is a risk factor for CRP and CRC. It is 
possible that petrol derivates and metals exert harmful effect upon colonic mucosa. Other 
exogenous risk factors are: use of anthranoid laxatives, working in petrol industry, 
production of synthetic materials, wood- and metal processing. Ionizing radiation increases 
the risk for CRC in radiation treatment of small pelvis after latent period of 15 years (Levin 
et al., 2002). 
9.2.8 Gut flora 
Pathological gut flora could produce potential carcinogens, deconjugate bile acids and 
impair cell DNA molecule (Aries et al., 1969). Our study ascertained the fact that H. pylori 
infection serves as a risk factor for CRC development. Similar results are reported from 
other authors (Zumkeller et al., 2006). However, more extensive studies are needed to prove 
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this observation. H. pylori could exert negative effect not only on upper parts of 
gastrointestinal tract, but may be also on colorectal mucosa. 
9.2.9 Association with other diseases 
Chronic and extensive IBD is connected with increased cell turnover and elevated risk of 
developing CRC. The risk for development of CRC in patients with IBD depends on the 
duration (8-10 years) and the extent of disease (Ekbom et al., 1990). We observed malignant 
transformation in one patient with ulcer colitis and inflammatory pseudopolyposis with 
duration more than 10 years. Some big population based studies have found slightly 
elevated risk of developing CRC in right colon in women 15 years after cholecystectomy 
(Ekbom et al., 1993). Acromegaly is associated with elevated risk for CRC (Jenkins et al., 
1997). We do not have any patient with acromegaly and CRP or CRC. We did not observe 
association between the patients who have undergone cholecystectomy and the frequency of 
CRC and CRP. The possible mechanism of this risk factor is associated with the constant free 
leakage of bile in the gut and with the toxic and carcinogenic effect of secondary bile salts. 
9.3 The mode of action of protective factors for colorectal polyps and cancer 
9.3.1 Probiotics 
Our data confirm that Bulgarian yoghurt (containing Lactobacilus acidophilus/bulgaricus and 
Streptococcus termophylus) has a protective effect on large bowel polyp formation.  Its use as a 
prophylactic seems perspective since it is traditionally present in Bulgarian national cuisine. 
9.3.2 Fibers 
According to our study the intake of large amounts of fibers is associated with reduced risk 
for CRP formation, although conflicting data exist. In a large prospective study, 
approximately 40% reduction of CRC risk in persons with high fiber consumption was 
reported (Bingham et al., 2003). The protective action of diet fibers is based on their 
capabilities to accelerate bowel transit time and enlarged volume, which could diminish 
exposition time of mucosa to food carcinogens and dilute them. Food fibers bind, inactivate 
and carry out the luminal carcinogens. Food fibers also decrease fecal pH and inhibit 
bacterial degradation of different alimentary compounds (Kritchevsky, 1995).  
9.3.3 Flavonoids 
Flavonoids are powerful antioxidants, which are found basically in fruit, vegetables, seeds, 
nuts, tea and wine (Middleton & Kandaswami, 1993). According to our data consumption of 
fruit and vegetables is protective factor for CRC and CRP, whereas regular consumption of 
tea is protective factor for CRP.  Flavonoids inhibit cell proliferation and induce apoptosis 
(Wenzel et al., 2000).  
9.3.4 Selenium 
In supranutrtional doses selenium has protective effect against development of CRC, cancer 
of prostate and lung cancer (Schatzkin et al., 1996). Its mode of action is based on its 
antioxidant, antiproliferative, and proapoptotic properties (Zhu et al., 2000). Selenium is 
www.intechopen.com
 
Risk and Protective Factors for Development of Colorectal Polyps and Cancer 
 
191 
basic part of the selenium-dependent glutathione-reductase, which removes free radical and 
protects the integrity of cell membrane and DNA stability. Selenium also activates tumor-
suppressor gene p53 (Seo et al., 2002). Our data in patients who use selenium as prophylaxis 
confirm its protective role.  
9.3.5 Calcium 
Our data show that consumption of milk products has protective effect against developing 
CRC and CRP. Calcium in milk products bind luminal bile and fat acids in insoluble soaps 
and inhibits proliferation of colon cells (Bostick et al., 1995). Calcium also enhances cell 
apoptosis in colon mucosa (Fedirko et al., 2009). Probably, calcium has a modulating role in 
the western diet, rather than anticarcinogenic properties. Optimal intake of calcium in >50 
year old persons is 1200 mg per day (Institute of Medicine, Dietary Reference Intakes for 
Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Food and Nutrition Board, 
Washington, DC., 1997). 
9.3.6 Fluid intake 
Regular intake of mineral water is protective factor for CRP according to our data. 
Epidemiological studies showed that protective effect of fibers depends on the volume of 
drank fluids (Lubin et al., 1997). This phenomenon is associated with the decreased 
concentration of carcinogens, accompanied with a high amount of fluid intake. 
9.3.7 Vitamins 
There are data that vitamin D, alone or in combination with calcium plays protective role for 
CRC (Hawk et al., 2004). Vitamin D induces cell differentiation and inhibits cell proliferation 
and metastatic potential (Giovannucci, 2006). Vitamin A has similar properties as vitamin D, 
but there is no clear evidence of its protective role for CRC. Significant side effects of 
vitamin D and vitamin A restrict their usage. No convincing data exist and for the protective 
role of folic acid for CRC. Combined use of some vitamins with antioxidant properties, like 
vitamin C and vitamin E, and minerals, like selenium could enhance their impact (Patterson 
et al., 2000). Our data confirm this result, because we used combination formula composed 
of vitamin E – 80 mg, vitamin C – 100 mg, ǃ-caroten – 10 mg and selenium – 250   μg) as  a 
prophylactic drug in 12 patients for period of 5 years. 
9.3.8 Bioactive compounds 
A lot of foods containing bioactive compounds are with protective effect for CRC and CRP 
according to our data – garlic, tea, fruit, vegetables, onions, grapes, vegetable food, legumes 
etc. Bioactive compounds include numerous chemical substances, which own anticancer 
properties (Greenwald, 2002). Some of the most studied bioactive compounds are found in 
green tea, tomatoes, and different sorts of onions, carrots, lemons and garlic. There are 
flavonoids and polyphenols in green tea, fruit and vegetables, which possess antioxidant 
properties. Bioactive compounds d-limonen and perilil alcohol are found in citrus fruit and 
their impact is associated with the induction of glutathione S-transferase. Red grapes have 
antioxidant properties, because of the bioactive compound resveratrol. In cereals and in 
beans are found phytoestrogens, which change the metabolism of steroid hormones. A lot of 
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bioactive compounds present in traditional Bulgarian cuisine. Therefore, it is reasonable to 
keep the tradition of healthy Balkan (Bulgarian)  diet from the first half of the 20-th century.  
9.3.9 Cereals 
Consumption of rye and whole grain bread are protective factors for CRP according to our 
data. Low incidence of CRC and other cancers is observed in countries with high 
consumption of complex long-chained carbohydrates, which is found in cereals (Gerber, 
2003). This fact is based on the presumption that complex long-chained carbohydrates 
successfully substitute fats as a source of energy. Recommended dose of cereals is 600-800 
gram per day. 
9.3.10 Fruit and vegetables 
Regular consumption of fruit and vegetables is a protective factor for CRC and CRP 
according to our data. Fruit and vegetables contain vitamins, minerals, biologically active 
substances and some insoluble fibers. All of them are regarded as protective. The suggested 
daily dose of fruit and vegetables is 400-800g/day divided in at least 5 meals. The protective 
role of regular consumption of fruits and vegetables is proven: the replacement of high 
calorie food with low calorie fruits and vegetables (cabbage and broccoli) decreases overall 
energy intake and reduce the risk for CRC. Compounds with hypothetical antiproliferative 
and anticancer action, which inactivate free radicals, are antioxidant vitamins (A, C, E), folic 
acid, thioethers (garlic, onions, leeks), terpens (citrus fruits), plant phenols (grapes, 
strawberries), carotenoids (carrots, sweet potatos, water melons), selenium, flavonoids, 
calcium, etc (Levin et al., 2002). With high consummation of fibres (cereals, fruits, 
vegetables) the risk for CRC is reduced with 40% (Guidance on Cancer Services. Improving 
Outcomes in Colorectal Cancers – Manual Update. National Institute for Clinical Excellence 
2004). Protective effect of fibers is augmented from the fluid intake, calcium, etc. (Levin et 
al., 2002).  
9.3.11 Dairy products  
Our study confirms that dairy products and yoghourt are protective factors for CRC and 
CRP, but low-fat dairy products must be available, in order to prevent cardiovascular 
diseases. Low-fat dairy products supply calcium and vitamin D, both of which has 
protective effect for CRC. The contradictory data about the protective role of dairy products 
is associated with the quantity of the contained fat (World Cancer Research Fund and 
American Institute for Cancer Research, Food, Nutrition and the Prevention of Cancer, 
1997).  
In summary, the intake of fats cause increased influx of bile in the small intestine, whereas 
part of the fat and bile reaches the large bowel, where bacteria metabolize fat and bile into 
bile acids and fat acids. These products impair the epithelium of large bowel and stimulate 
cell proliferation, which is a prerequisite for carcinogenesis of large bowel. The secondary 
products of bile metabolism and by-products of some foods, which are cooked in certain 
way, could act like carcinogens, especially in persons with genetic predisposition for 
development of CRC. The food exerts effect upon intraluminal content and wall of the large 
bowel, but also part of the digested substances are absorbed and release of the local 
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hormones and peptides, like insulin and gastrin, is induced. These hormones and peptides 
could also promote epithelial hyperploliferation. Apoptosis and cell differentiation are 
suppressed too, and DNA abnormalities could occur (Fig. 1). Adenomatous, hyperplastic or 
mixed colorectal polyps are morphological sign of the blended influence of genetic and 
exogenous factors upon the colorectal epithelium. Occurrence and progression of these 
polyps are evidence for the readiness of the colorectal epithelium to react in this distinct 
way under the influence of exogenous risk factors and inherited predisposition. Diet fibers 
by their volume and fluids dilute large bowel content, shorten the bowel transit time and do 
not permit a long contact of large bowel content with large bowel wall. As a result of  
bacterial fermentation of the cereal fibers, short-chain fatty acids are produced, which are 
very important for the metabolism and proper state of large bowel epithelium and 
contribute to large bowel integrity (Hague et al., 1995). Changed low pH in the large bowel 
inhibits dehydroxylation and dehydrogenation of bile acids. Changed low pH in the large 
bowel plays protective role for occurrence of CRC, because dehydroxylation and 
dehydrogenation of bile acids could result in formation of carcinogenic substances.  
 
Fig. 1. Possible mechanisms of influence of diet and lifestyle upon pathogenesis of colorectal 
cancer. IFG-1, insulin-like growth factor-1; COX-2, cyclooxygenase-2. 
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Micronutrients and bioactive compounds complete their protective role by several 
mechanisms – in systemic way promote cell differentiation and apoptosis, and support the 
large bowel integrity, while intraluminally, micronutrients and bioactive compounds 
participate actively in detoxification of diet and metabolite carcinogens. Influence of the 
environmental risk factors, especially diet risk factors, could facilitate the clinic expression 
of recessive alleles for CRC or alleles with low penetration. Diet risk factors could also 
modulate the time of expression of recessive alleles for CRC. This statement could explain 
some of the cases of CRC in patients from a generation, which has been migrated from 
countries with low incidence of CRC in countries with high incidence of CRC (USA, 
Australia). Often, systemic genetic variations (polymorphisms) could affect the speed of 
detoxification or the activation of environmental carcinogens. This is happening in the 
process of the culinary food treatment, during tobacco smoking or from the alcohol 
metabolites. At the same time, shortage of anticarcinogens could be available in the regular 
diet.  
We must not forget that from the two known etiological risk factors, the first is acquired – 
diet and lifestyle, and the second one is inheritable – susceptibility. Large bowel polyposis is 
a very good example of the interactions between exogenous and endogenous factors that 
take part in large bowel carcinogenesis with different rate of progression. In patients with 
FAP the progression from benign adenomas to cancer is rapid (2-4 years) due to inherited 
genetic changes; in other cases longer exposure to certain exogenous factors is needed to 
cause genetic changes that lead to cancer (the mean age of CRC patients in оur group was 64 
years); however, in certain subjects the time for neoplastic transformation exceeds life 
duration. Therefore a good differentiation between these groups and early prophylaxis and 
screening methods are needed. The most frequently used screening methods include: 
flexible sigmoidoscopy, fecal occult blood test, large bowel capsule endoscopy (if cheaper), 
double contrast barium enema, virtual colonoscopy, fibrocolonoscopy, endoscopic 
polypectomy, histological evaluation of all removed polyps, assessment of risk factors, and 
genetic testing if possible. In conclusion about 15% of the cases with CRC are hereditary, 
while the remaining 85% are sporadic. However, in 30% of cases a stronger correlation with 
dietary habits and lifestyle is suspected, while in 55% a close interaction between host 
susceptibility and environmental factors is more probable. The above fact leads us to the 
hypothesis that prevention of CRC is a possible task, which can be achieved by correction of 
certain exogenous factors. 
10. Chemoprevention 
Chemoprevention is defined as a usage of a medication or natural substances, which can 
prevent occurrence of benign or malignant tumor (Hakama, 1998).  Chemoprevention is 
used in every stage of CRC prevention and includes three major groups: medications, non-
medications and biologically active substances. Medications include non-steroidal anti-
inflammatory drugs (NSAIDs), acetylsalicylic acid, inhibitors of cyclooxigenase-2 (СОХ-2), 
5-aminosalicylic acid (5-ASA), folic acid, ursodeoxycholic acid, difluoromethylornithine 
(DFMO), dithiolethionine (oltipraz), acetilcystein, etc. Non-medications are: selenium, fibers, 
calcium, vit A, B, C, D, ǃ-carotene, other retinoids, minerals, etc. Biologically active 
substances include: limonene and perillyl alcohol (in citruses), resveratrol (red grape), 
diallyl disulfide (garlic), lycopene (tomatoes), flavanols (green tea), isoflavones – genistein 
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(soya), dithiolthiones, squalene (olive oil), ferulic and phytic acids (rice). Chemoprevention 
plays a substantial role in secondary and tertiary prevention of CRC. Also, it could be used 
for prophylaxis in patients after polypectomy of adenomas with high-grade dysplasia, 
polyps with invasive carcinomas, patients with familial history for cancer. Patient with IBD 
and inflammatory pseudopolyposis and require constant chemoprevention with 5-ASA. The 
most widely used medications include: acetylsalicylic acid, polyvitamins, folic acid, 
selenium, NSAID. So far, the most consistent data for reduction of polyp recurrence exist for 
acetylsalicylic acid and folic acid. Still, more large studies, examining the exact medications 
and possible role, are needed.  
10.1 NSAIDs  
Mechanisms of chemoprevention with NSAIDs include: inhibition and deactivation of 
possible carcinogens, inhibition of cell proliferation, promotion of cell differentiation and 
apoptosis, correction of genetic damages and inhibition of angiogenesis (Gustafson-Svard et 
al., 1996). Epidemiological studies have shown that NSAIDs and especially acetylsalicylic 
acid have chemopreventive properties (Lang, 2003). Regression of polyps to 28% is detected 
in FAP patients, who are treated in a long period with NSAIDs (Steinbach et al., 2000). The 
regular intake of acetylsalicylic acid and other NSAIDs reduce the incidence of CRC with 30-
50% according to retrospective and prospective studies (Janne & Mayer, 2000). However, 
adenomas are observed in some patients, who are treated with acetylsalicylic acid, which 
means that chemoprevention cannot substitute completely screening colonoscopy (Sandler 
et al., 2003). The dose of acetylsalicylic acid is still debatable. Some studies show that 
reduction of the risk for colorectal polyp occurrence is achieved with lower doses of 
acetylsalicylic acid (Baron et al., 2003). Side effects of long intake of acetylsalicylic acid, like 
gastrointestinal hemorrhage and brain hemorrhage restrict the usage of acetylsalicylic acid. 
There is a need for development and usage of new forms of acetylsalicylic acid and NSAIDs 
agents, which are much safer, like NO-acetylsalicylic acid (Fiorucci & Del Soldato, 2003). 
Another possibility is the usage of products and substances of natural origin. For example, 
natural COX-2 inhibitors are yellow pigment curcumin, resveratrol (in grapes) and omega 3-
fatty acids in the fish.  
10.2 Folic acid 
The presumable protective mechanism of folic acid is not clear, but it is supposed, that the 
lack of folic acid is associated with hypomethylation of DNA and oncogenic activation. 
Regular intake of folic acid for at least 15 years reduces the risk of development of CRC 
(Giovannucci et al., 1998). A study showed reduction of CRC incidence in genetically 
predisposed persons who use folic acid in high doses. Probably, these persons are 
vulnerable to methyl group deficiency, as a result of DNA aberrations with low 
penetration (Fuchs et al., 2002). The risk for CRC is vastly reduced if folic acid is used for 
a prolonged time, especially from smokers (Scottish Intercollegiate Guidelines Network. 
Management of Colorectal cancer. A national clinical guideline. 2003). However, there are 
data from animal studies that folic acid can promote the impact of some carcinogens (Kim, 
2003). Moreover, no large studies are available to sustain the chemopreventive role of folic 
acid.   
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Protective role of calcium is confirmed in different trials. A result from a study claims that 
regular daily intake of 3 g calcium as supplement reduce the risk of colorectal adenomas 
relapse 1 year after their removal. This fact is an evidence of protective action of calcium in 
the early stages of colorectal carcinogenesis (Baron et al., 1999). Another study reported that 
high calcium intake is associated with vastly lower risk of development of distal CRC, but 
not proximal CRC (Wu et al., 2002). 
10.4 Ursodeoxycholic acid 
The protective role of ursodeoxycholic acid for CRC is probably due to the reduced 
absorption of the secondary deoxycholic acid, which increases epithelial proliferation and 
promote carcinogenesis. A study proved that use of synthetic ursodeoxycholic acid is 
associated with reduced risk of development of CRC in patients with ulcerative colitis and 
primary sclerosing cholangitis (Peng et al., 1995). Other authors found that administration of 
ursodeoxycholic acid in patients with primary biliary cirrhosis, who have undergone 
polypectomy, is connected with vastly reduced risk of CRP relapse (Serfaty et al., 2003).  
10.5 Selenium 
Abundant data for the role of selenium as a prophylactic substance for the CRC are 
constantly accumulating. Epidemiological studies have shown anticancer role of selenium 
since 1970. In some parts of Europe there is low amount of selenium in the soil and 
European population show tendency of lower intake of selenium in the last 25 years 
(Rayman, 2000). A lower risk for CRC was detected in persons who take 200 g selenium 
daily (Clark et al., 1996). Some authors found lower serum levels of selenium in patients 
with CRC (Scieszka et al., 1997). 
We can conclude that the choice of proper chemopreventive tool is difficult. Such a tool 
must be effective, cheap, safe and easy to use. It is calculated, that up to 80% of the cases 
with CRC could be prevented by alteration of diet habits (Cummings & Bingham, 1998). 
These data oblige us to fully clarify the role of chemoprevention in colorectal neoplasms. 
Combination of chemoprevention with screening endoscopy is of great importance for 
reduction of the CRC mortality. The most significant chemopreventive agents are the 
acetylsalicylic acid and other NSAIDs, antioxidants, calcium and selenium.  
10.6 Chemoprevention in our patients 
The main indications for applying chemoprevention in our patients were: patients with 
adenomatous polyposis of large bowel; patients who have undergone endoscopic 
polypectomy; operated for CRC patients, IBD patients and patients with hereditary 
syndromes of CRC. 70 of our patients took chemopreventive agents: acetylsalicylic acid, 
polyvitamins, folic acid, selenium, NSAID, calcium, 5-ASA, ursodeoxycholic acid. 
11. Primary prophylaxis of colorectal adenomatous polyps and CRC  
Colorectal cancer prevention is divided into three groups: primary, secondary and tertiary. 
Diet and lifestyle are considered as targets in primary CRC prevention, which includes 
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modification of the established risk factors for colorectal polyps. These are: limitation of 
certain foods, beverages and habits; improved physical activity; consumption of protective 
foods; eradication of H. pylori. Important question is whether it is possible to apply primary 
prophylaxis in CRC and its precursor – adenomatous colorectal polyposis and if risk factors 
for CRC and CRP are avoidable and at what extent? Considering the growing epidemic of 
CRC this issue is waiting its prompt answer. What kind of healthy style of life we can offer 
to threatened people, similarly to the primary prevention in other diseases like 
cardiovascular disease, ischaemic heart disease and arterial hypertension, and distinct type 
of cancers?  A great part of risk factors for CRC and CRP are associated with the diet, the 
lifestyle, exogenous carcinogens, some diseases and disease-like conditions. However, some 
protective factors for CRC and CRP are famous and could be recommended. As a primary 
prevention in healthy persons change of diet habits, reduction of body weight, refusal of 
tobacco smoking and alcohol intake are recommended. Preventive role of calcium, 
magnesium, ǃ-carotene, vitamins, folic acid and selenium for CRC and CRP is still 
disputable. Acetylsalicylic acid and other NSAIDs for this purpose are not commonly used, 
because of their adverse side effects (Sandler, 2004). However, if new and convincing data 
are available, we can try to restrict influences of known risk factors and to cure precancerous 
conditions and will be able to perform proper primary prevention for CRC and colorectal 
adenomatous polyposis. 
12. Secondary prophylaxis of colorectal adenomatous polyps and CRC  
Secondary CRC prevention is used for early detection of premalignant adenomas and cancer 
in its curative stage. It includes: screening colonoscopy; polypectomy; optimal treatment of 
IBD patients; chemoprevention and follow-up (Hawk, 2004; Rex, 2000). The aim of 
secondary prophylaxis or screening is to diminish the mortality of CRC by early detection 
and treatment of premalignant adenomas and cancer in its curable stage. European and 
national gastrointestinal and digestive endoscopy societies recommend screening to 
comprehend all healthy and risk groups of people. CRC screening consists of: digital rectal 
examination, fecal occult blood test, fecal immunochemical test for 
haemoglobin/haptoglobin, barium enema, sigmoidoscopy, sigmoidoscopy with fecal occult 
blood test, colonoscopy (with polypectomy), chromoendoscopy, NBI and high-resolution 
colonoscopy, virtual colonoscopy - CT or MRI, fecal DNA test (Geissler & Graeven, 2005). A 
useful test is invented for early detection and follow-up of CRC, similar to the noninvasive 
serological and fecal tests used for detection of infection with H. Pylori. This test is based on 
the idea, that proliferating cells, especially malignant cells, are expressing special isoenzyme 
of pyruvate kinase (PK), which plays a significant role in glycolysis. This isoenzyme consists 
of 4 subunits in healthy cells, while in neoplastic cells there are 2 subunits. This dimeric 
form M2-PK is found in gastrointestinal neoplasms. Tumor marker M2-PK is found in the 
blood of 47.8% of patients with CRC, while fecal test is sensible in 80% of cases with CRC 
(Hardt et al., 2004).  
We propose stratification of healthy population in three groups: patients with moderate risk 
for development of colorectal polyps and cancer; patients with elevated risk for development 
of colorectal polyps and cancer; patients with extremely high risk for development of 
colorectal polyps and cancer;  
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The first group includes all patients who have no family history for cancer and no personal 
history for polypectomy or cancer in the past. 
The second group includes patients with family history for CRC or related neoplasia 
(stomach, mammary gland, endometrium, ovary, adrenal glands), patients with 
polypectomy of polyps with low-grade dysplasia, patients with large bowel resection due to 
CRC (5 years post-surgery), male gender. 
The third group includes patients: with familial adenomatous polyposis (FAP), with 
polypectomy of polyps with high-grade dysplasia, patients with large bowel resection due 
to CRC (up to 5 years post-surgery), with Peutz-Jeghers syndrome, juvenile polyposis, 
Cowden`s disease, HNPCC, IBD patients, with acromegaly and ureterosigmoidostomy.  
The most appropriate follow-up method of patients, who have undergone polypectomy, is 
colonoscopy. The intervals according to the patients` risk and starting age are summarized 




Starting age for 
screening colonoscopy 
Interval for control 
colonoscopy 
1 
With average statistical risk for 
development of CRP and CRC 
50 years 10 years 
2 With moderately elevated risk for CRC 40 years 5 years 
3 With extremely high risk for CRC 10-30 years 1-3 years 
Table 7. Starting age and intervals for screening colonoscopy. 
13. Tertiary prophylaxis of CRC  
Follow-up, chemoprevention and polypectomy are cornerstones of tertiary CRC prvention. 
Tertiary prevention is performed after surgical treatment for CRC and its aim is elongation 
of the survival and improvement of the quality of life of patients who have been treated 
with resection for curable CRC. This purpose can be achieved by treatment of the patient’s 
complaints, which are connected with the primary disease or with the systemic 
chemotherapy, as well and by disclosure of relapses in early and curable stage. We have not 
to forget, that occupational and psychosocial rehabilitation are very important in these 
patients. Large studies, which offer standard approach to these patients, are missing. 
Nevertheless, the following factors must be considered: tumor stage, general condition of 
the patient and life expectancy, and the patient’s gain from treatment with a new, 
potentially curable surgeon intervention in case with proven relapse of CRC. 8,4 % of our 
patients develop metachronous CRC with mean age 69±11 years. The mean difference 
between diagnosis (CRC) of first and second localization is 6 years (2-15). This is the time for 
tertiary prophylaxis of CRC.  
Follow-up of patients with CRC is achieved by: personal history, physical examination, 
carcinoembryonic antigen (CEA) test, lab tests, fecal occult blood test, chest X-ray, 
abdominal ultrasound, echo-endoscopy, CТ, MRI, colonoscopy and PET-CT.  
In conclusion, primary prophylaxis of the disease is the ultimate aim of every clinical 
physician. Can we apply the primary prophylaxis in colorectal adenomas and CRC? 
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Encouraging examples for this possibility exist. Low physical activity, high uptake of 
saturated fats and arterial hypertension were recognized as risk factors for cardiovascular 
diseases. For a few years broad public campaigns resulted in dramatic reduction of 
mortality from coronary heart disease. Similar results are obtained and in some countries, in 
which restrictive government politics for tobacco smoking exists. No single factor is 
responsible for CRC carcinogenesis, but combination of some important factors, which are 
associated with the diet and lifestyle, is crucial. 
May be the true pathway is to seek some average healthy diet and lifestyle, which play 
preventive role for many diseases. This recommendation is especially useful for the persons 
who are genetically predisposed, because the environmental risk factors can promote faster 
carcinogenesis. 
Revival of the healthy Balkan (Bulgarian) feeding habits from the first half of the 20-th 
century seems reasonable (Ribarova et al., 2004). More protective foods must be included in 
our daily meal and this task looks feasible. We have to consume regularly fruit, vegetables, 
cereals, low-fat dairy products, legumes, poultry, fish, sea products, fibers and to reduce the 
intake of animal fats, red meat and preserved food. We have to be physical active, restrict 
alcohol usage, and to avoid tobacco smoking and usage of grilled and fried food. 
Many countries introduced a large scale programs for reduction of risk factors and 
promotion of protective factors for CRC. Besides that, such programs are useful and for 
prophylaxis of cardiovascular diseases, some other cancers and important metabolite 
diseases, like diabetes mellitus II type and obesity. 
14. Recommendations for prophylaxis of CRC according to our data 
You must follow these rules to be protected from colorectal cancer: 
1. Do not eat fatty food, smoked meat, fried foods, margarine, pork, red meat and egg-
fried food  
2. Do not drink alcohol 
3. Do not smoke 
4. Sustain high physical activity and do not be obese  
5. Restrict the intake of refined sugar and white flour products 
6. Use plant oil, but not margarine 
7. Legumes, fish, low-fat dairy products and Bulgarian yoghourt are good source of 
proteins 
8. Consume at least 5 times per day fruits and vegetables (pears, melons, water melons, 
grapes, peaches, onion, garlic, pepper)  
9. Prefer poultry, white meat, hares and fish from the meat 
10. Healthy cooking includes decrease of the fat added in the food, reduction of the 
cooking temperature and refraining from the use of grilled food 
11.  Do not use regularly laxatives  
12.  Avoid contact with petrol  
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14.  Fasting is good 
15.  Do endoscopic polypectomy if you have adenomatous colorectal polyps 
16.  Eradicate Helicobacter pylori if you are infected 
17.  Use daily acetylsalicylic acid if you do not have any contraindications 
18.  Make a screening colonoscopy after you reach 50 years, and if you are in risk group 
(familial predisposed to colorectal cancer or associated localization – stomach, 
endometrium, breast, ovary or if you have preceding polypectomy) – after you reach 40 
years. Consider genetic testing if you are in  risk groups  
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